Stock Analysis

Insider-Owned Growth Giants On The Indian Exchange In July 2024

Published

In the past year, the Indian stock market has shown remarkable growth, rising by 45%, although it remained flat over the last week. Against this backdrop of robust annual growth and promising earnings forecasts, companies with high insider ownership can be particularly compelling, as they often reflect a deep commitment from those who know the business best.

Top 10 Growth Companies With High Insider Ownership In India

NameInsider OwnershipEarnings Growth
Archean Chemical Industries (NSEI:ACI)22.9%28.9%
Pitti Engineering (BSE:513519)30.3%28.0%
Kirloskar Pneumatic (BSE:505283)30.6%29.8%
Shivalik Bimetal Controls (BSE:513097)19.5%28.7%
Jupiter Wagons (NSEI:JWL)10.8%27.2%
Rajratan Global Wire (BSE:517522)19.8%33.5%
Dixon Technologies (India) (NSEI:DIXON)24.9%34.5%
Paisalo Digital (BSE:532900)16.3%23.8%
JNK India (NSEI:JNKINDIA)23.8%31.8%
Pricol (NSEI:PRICOLLTD)25.5%26.9%

Click here to see the full list of 83 stocks from our Fast Growing Indian Companies With High Insider Ownership screener.

Let's dive into some prime choices out of from the screener.

HealthCare Global Enterprises (NSEI:HCG)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HealthCare Global Enterprises Limited operates in the healthcare sector, primarily offering services related to cancer and fertility, with a market capitalization of approximately ₹50.33 billion.

Operations: The company generates ₹19.12 billion from setting up and managing hospitals and medical diagnostic services.

Insider Ownership: 13.8%

Revenue Growth Forecast: 12.1% p.a.

HealthCare Global Enterprises, a key player in India's healthcare sector, demonstrates robust growth with a 64% earnings increase over the past year. Despite lower-than-average forecasted Return on Equity at 11.7%, earnings are expected to rise by 38.2% annually, outpacing the Indian market prediction of 15.9%. Recent strategic moves include discussions on acquiring Vizag Hospital, highlighting expansion efforts despite challenges in covering interest payments with earnings and no significant insider trading activity noted recently.

NSEI:HCG Earnings and Revenue Growth as at Jul 2024

Persistent Systems (NSEI:PERSISTENT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Persistent Systems Limited is a global company based in India that offers software products, services, and technology solutions, with a market capitalization of approximately ₹70.73 billion.

Operations: Persistent Systems generates revenue from three primary segments: Healthcare & Life Sciences (₹20.88 billion), Software, Hi-Tech and Emerging Industries (₹45.95 billion), and Banking, Financial Services and Insurance (BFSI) at ₹31.39 billion.

Insider Ownership: 34.3%

Revenue Growth Forecast: 13.5% p.a.

Persistent Systems, an Indian technology company, shows moderate growth prospects with its revenue and earnings forecasted to grow at 13.5% and 18.1% annually, respectively—both rates surpassing the broader Indian market averages. While the company's Return on Equity is expected to be strong at 26.4%, it pays a modest dividend yield of 0.54%. Recent activities include executive changes and approval of dividends at its AGM, alongside launching innovative platforms like GenAI Hub to bolster enterprise AI applications.

NSEI:PERSISTENT Ownership Breakdown as at Jul 2024

Praj Industries (NSEI:PRAJIND)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Praj Industries Limited specializes in bio-based technologies and engineering solutions globally, with a market capitalization of approximately ₹132.49 billion.

Operations: The company generates ₹34.66 billion in revenue from its Process and Project Engineering segment.

Insider Ownership: 29.1%

Revenue Growth Forecast: 16.5% p.a.

Praj Industries, a key player in India's growth sector with high insider ownership, has shown robust financial performance with a 34.6% annual earnings growth over the past five years and is projected to grow by 20.1% annually. Despite revenue growth forecasts being slightly slower at 16.5% yearly, it outpaces the Indian market average of 9.7%. However, its dividend coverage is weak due to low free cash flow. Recent board decisions include significant dividends and executive appointments, enhancing governance strength.

NSEI:PRAJIND Earnings and Revenue Growth as at Jul 2024

Turning Ideas Into Actions

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're helping make it simple.

Find out whether HealthCare Global Enterprises is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com